POSTING AGREEMENTPosting Agreement • December 20th, 2021 • Oracle Health, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledDecember 20th, 2021 Company Industry Jurisdiction[Oracle Health, Inc][COMPANY], a [Delaware][STATE] [C-Corp][ENTITY] located at [910 Woodbridge Ct. Safety Harbor, FL 34695][ADDRESS] (the “Company”), proposes, subject to the terms and conditions contained in this Posting Agreement (this “Agreement”), to issue and sell shares of its [3,000,000 shares of common stock ($2/share)][SECURITIES], $XXX par value per share (the “Shares”) to investors (collectively, the “Investors”) in a public offering (the “Offering”) on the online website provided by StartEngine Crowdfunding, Inc. (the “Platform”) pursuant to Regulation A through StartEngine Primary LLC ( “StartEngine”), acting on a best efforts basis only, in connection with such sales. The Shares are more fully described in the Offering Statement (as hereinafter defined).
EMPLOYMENT AGREEMENTEmployment Agreement • April 21st, 2022 • Oracle Health, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledApril 21st, 2022 Company Industry JurisdictionEMPLOYMENT AGREEMENT (this “Employment Agreement”), dated as of January 7, 2022, between Oracle Health, Inc., a Delaware corporation (the “Company”), and Jaeson Bang, an individual (the “Executive”).
OFFERING LISTING AGREEMENTOffering Listing Agreement • January 12th, 2021 • Oracle Health, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJanuary 12th, 2021 Company Industry JurisdictionThis Offering Listing Agreement (this “Agreement”) is effective as of January 7, 2021 (the “Effective Date”) by and among Oracle Health, Inc., a Delaware corporation (“Issuer”), and OpenDeal Broker LLC dba the Capital R (“ODB”), a New York limited liability company. Issuer and ODB are hereby referred to collectively as the “Parties” or individually as a “Party”.
ContractOracle Health, Inc. • October 29th, 2020 • Delaware
Company FiledOctober 29th, 2020 JurisdictionTHIS INSTRUMENT AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE ACT. FOR ONE YEAR FROM THE DATE OF THIS INSTRUMENT, SECURITIES SOLD IN RELIANCE ON REGULATION CROWDFUNDING UNDER THE ACT MAY ONLY BE TRANSFERRED TO THE COMPANY, TO AN “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501 OF REGULATION D UNDER THE ACT, AS PART OF AN OFFERING REGISTERED UNDER THE SECURITIES ACT WITH THE SEC, OR TO A MEMBER OF INVESTOR’S FAMILY OR THE EQUIVALENT, TO A TRUST CONTROLLED BY THE INVESTOR, TO A TRUST CREATED FOR THE BENEFIT OF A MEMBER OF THE FAMILY OF THE INVESTOR OR EQUIVALENT, OR IN CONNECTION WITH THE DEATH OR DIVORCE OF THE INVESTOR OR OTHER SIMILAR CIRCUMSTANCE. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC, ANY STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY,
SUBSCRIPTION AGREEMENT ORACLE HEALTH, INC. Regulation ASubscription Agreement • October 29th, 2020 • Oracle Health, Inc. • Florida
Contract Type FiledOctober 29th, 2020 Company JurisdictionThis Subscription Agreement (this “Agreement”) is made between Oracle Health, Inc. (the “Company”) and the investor executing this Agreement (the “Investor”). Pursuant to terms and conditions of this Subscription Agreement, and subject to its terms and conditions, the Company agrees to sell to the Investor, and the Investor agrees to purchase, that certain number of shares representing a $[ ] investment previously specified by the Investor to the Company (the “Shares”) of the Company’s common stock, par value of $0.00001 per share, relating to the exempt offering by the Company (the “Offering”) for up to 4,000,000 shares of the Company’s common stock for aggregate maximum gross proceeds of $8,000,000. The purchase price of such Shares is $2.00 per share.
Research Collaboration AgreementResearch Collaboration Agreement • October 29th, 2020 • Oracle Health, Inc.
Contract Type FiledOctober 29th, 2020 Company● OH develops, manufactures and markets state of the art technology in the field of cardiac monitoring for application in the medical sector;
Wefunder Listing AgreementWefunder Listing Agreement • September 5th, 2024 • Future Cardia, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledSeptember 5th, 2024 Company IndustryTHIS LISTING AGREEMENT is made on June 17th 2024 by and between Future Cardia, Inc, a NevadaCorporation (the “Company”), and Wefunder Portal, LLC, a Delaware limited liability company (“Wefunder Portal,” “we” or “us”). The parties hereby agree as follows:
CREDIT CARD SERVICES AGREEMENTServices Agreement • December 20th, 2021 • Oracle Health, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledDecember 20th, 2021 Company IndustryThis Services Agreement (“Services Agreement” or “Agreement”) is entered into as of the date noted below (the “Effective Date”) between StartEngine Crowdfunding, Inc., a Delaware corporation (“Company”), and Oracle Health, Inc a Delaware C corporation (“Customer” or “you”).
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • June 14th, 2022 • Oracle Health, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJune 14th, 2022 Company IndustryThis AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of June 7, 2022, is entered into by and between Oracle Health, Inc., a Nevada corporation (the “Oracle NV”), and Oracle Health, Inc., a Delaware corporation (“Oracle DE”). Oracle NV and Oracle DE are sometimes together referred to herein as the “Constituent Entities.”
LICENSE AGREEMENTLicense Agreement • October 29th, 2020 • Oracle Health, Inc. • Texas
Contract Type FiledOctober 29th, 2020 Company JurisdictionThis License Agreement (the “Agreement”) is made as of the 18th of NOVEMBER , 2019, between Texas Medical Center, a Texas non-profit corporation, as Licensor (the “Licensor”), and ORACLE HEALTH, INC., as Licensee (the “Licensee”).
TMCx ACCELERATOR PROGRAM PARTICIPATION AGREEMENTTMCX Accelerator • October 29th, 2020 • Oracle Health, Inc. • Texas
Contract Type FiledOctober 29th, 2020 Company JurisdictionThis TMCx Accelerator Program Participation Agreement (the “Agreement”) is entered into as of the Effective Date (defined below) between Texas Medical Center, a Texas non-profit corporation (“TMC”) and Participant (defined below). TMC and Participant are each sometimes referred to as a “Party” and collectively as the “Parties”.
SERVICES AGREEMENTServices Agreement • December 20th, 2021 • Oracle Health, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledDecember 20th, 2021 Company IndustryThis Services Agreement (“Services Agreement” or “Agreement”) is entered into as of the date noted below (the “Effective Date”) between StartEngine Crowdfunding, Inc., a Delaware corporation (“Company”), and Oracle Health, Inc a Delaware C corporation (“Customer” or “you”).
ContractCompany Engagement and Posting Agreement • April 26th, 2023 • Future Cardia, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledApril 26th, 2023 Company IndustryThis COMPANY ENGAGEMENT and POSTING AGREEMENT (the “Agreement”) is made as of 11/22/2022, by and among StartEngine Capital LLC, a Delaware limited liability (“StartEngine Capital”), and Future Cardia, [Legal Company Name] a Nevada / C-Corporation [State/ Type of Entity] (the “Company”).
PATENT LICENSE AGREEMENTPatent License Agreement • December 11th, 2020 • Oracle Health, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledDecember 11th, 2020 Company Industry JurisdictionThis PATENT LICENSE AGREEMENT (this “Agreement”) is dated as of the 21 day of September, 2020, (the “Effective Date” ) by and between Jaeson Bang, an individual, (the “Individual”), and ORACLE HEALTH, INC. a Delaware corporation (the “Company”).